SCHEMBL13016388

SCHEMBL13016388

Ic1c(-c2cccc(-c3cc4ccccc4c4ccccc34)c2)c2ccccc2c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.46
▸ ALDH1A1 P00352 4/20 0.41
▸ HPGD P15428 3/20 0.41
▸ HIF1A Q16665 3/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CASP1 P29466 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ MPI P34949 1/20 0.39
▸ TRPM4 Q8TD43 1/20 0.36
▸ GPR84 Q9NQS5 4/20 0.36
▸ CYP1B1 Q16678 1/20 0.35
▸ ALOX5 P09917 3/20 0.35
▸ NISCH Q9Y2I1 1/20 0.34
▸ RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4316197 0.88 CYP11B1 (0.53) CYP11B1ALDH1A1HPGDHIF1AHSD17B10
SCHEMBL13017653 0.87 MCL1 (0.41) ALDH1A1HPGDHSD17B10MAPK1TSHR
SCHEMBL13016379 0.86 CYP11B1 (0.45) CYP11B1ALDH1A1HPGDHIF1AHSD17B10
SCHEMBL31690682 0.84 CYP11B1 (0.50) CYP11B1ALDH1A1HPGDHIF1AHSD17B10
SCHEMBL12520786 0.82 CYP11B1 (0.58) CYP11B1ALDH1A1HPGDHIF1AHSD17B10
SCHEMBL13820837 0.81 CYP11B1 (0.41) CYP11B1ALDH1A1HPGDHIF1AHSD17B10
SCHEMBL13017648 0.80 HSD17B1 (0.47) CYP11B1CYP1B1ALOX5CYP1A2CYP2D6
SCHEMBL18631543 0.80 CYP11B1 (0.46) CYP11B1ALDH1A1HPGDHIF1AHSD17B10
SCHEMBL13706666 0.79 CYP11B1 (0.51) CYP11B1ALDH1A1HPGDHIF1AHSD17B10
SCHEMBL30340805 0.78 CYP11B1 (0.55) CYP11B1ALDH1A1HPGDHIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8568903-B2 Phenanthrene derivative, and material for organic EL element IDEMITSU KOSAN CO., LTD. (JP) 2013-10-29 — — US disclosed
US-8568903-B2 Phenanthrene derivative, and material for organic EL element IDEMITSU KOSAN CO., LTD. (JP) 2013-10-29 — — US disclosed
US-20100327230-A1 PHENANTHRENE DERIVATIVE, AND MATERIAL FOR ORGANIC EL ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2010-12-30 — — US disclosed
US-20100327230-A1 PHENANTHRENE DERIVATIVE, AND MATERIAL FOR ORGANIC EL ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2010-12-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327230-A1 PHENANTHRENE DERIVATIVE, AND MATERIAL FOR ORGANIC EL ELEMENT LEF1, AR, NR0B1 CYP11B1 630/4885ALDH1A1 1250/4885HPGD 3401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback